Clinical Trials on Penetrating Ulcers in Russian Federation

Total 118 results

Biotec Pharmacon ASA

Completed

Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients

Foot Ulcer

Russian Federation
Research Center Matrix

Completed

LLLT of Trophic Ulcers of Lower Extremities and Chronic Venous Insufficiency

Chronic Venous Insufficiency | Trophic Ulcers

Russian Federation
Human Stem Cell Institute, Russia
Ryazan State Medical University; Vidnoe District Hospital

Completed

Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Diabetic Foot

Ulcers Related to Diabetic Foot Syndrome

Russian Federation
Valenta Pharm JSC

Not yet recruiting

Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers

Heartburn | Acid-dependent Diseases of the Gastrointestinal Tract | Symptomatic Treatment of Gastric and Duodenal Ulcers

Russian Federation
Voronezh N.N. Burdenko State Medical Academy

Completed

New Technologies for Endoscopic Treatment of Bleeding Gastroduodenal Ulcers

Ulcer Hemorrhage

Russian Federation
Ural State Medical University

Unknown

The Study of the Effectiveness of Tissue Equivalent on the Basis of Cultured Cells to Heal Skin Blemishes (SETES)

Burns | Neurotrophic Ulcers

Russian Federation
AstraZeneca

Completed

Helicobacter Pylori Eradication Treatment in Patients With Duodenal Ulcers

Duodenal Ulcer

Russian Federation
State Budgetary Healthcare Institution, National...

Completed

Comparative Assessment of Effectiveness and Safety of Methods for Skin and Hair Care in Severe Intensive Care Unit Patients

Pressure Ulcer

Russian Federation
Federal State Budgetary Institution, V. A. Almazov...

Recruiting

Ulcers Formation After Hand-Sewn vs Stapled Gastrojejunal Anastomosis In MGB. (ULTRA)

Ulcer Peptic

Russian Federation
Enrollme.ru, LLC
Danone Nutricia

Completed

Study to Assess the Clinical Efficacy of the Specialized Enteral Tube Nutrition Composition Nutrison Advanced Cubison as a Part of Complex Pressure Ulcers (PU) Therapy

Pressure Ulcer ( Stage 2-3)

Russian Federation
Rovi Pharmaceuticals Laboratories

Completed

Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers

Foot Ulcer, Diabetic

Croatia, Poland, Romania, Russian Federation, Serbia, Spain
Private Healthcare Institution Clinical Hospital...

Recruiting

Evaluation of Biliary Reflux After Mini-gastric Bypass With Using the Biliary Reflux Index

Bile Reflux | Ulcer, Gastric

Russian Federation
State Scientific Centre of Coloproctology, Russian...

Completed

Russian Extremely Severe Ulcerative Colitis Study (REXs_UC)

Inflammatory Bowel Diseases | Ulcerative Colitis

Russian Federation
Russian Academy of Medical Sciences
Dr. Falk Pharma GmbH

Completed

Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERD (OGIG-130-1)

Gastroesophageal Reflux Disease

Russian Federation
OcuNexus Therapeutics, Inc.

Completed

A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE) (DUNE)

Diabetic Foot Ulcers

Russian Federation, United States, Ukraine
Pfizer

Completed

The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)

Diabetic Foot Ulcer

Canada, Austria, Czech Republic, Sweden, Russian Federation, Poland, Norway, United Kingdom, Italy, Belgium, Denmark, Germany, Greece, Ukraine
Federal State Budgetary Scientific Institution...

Recruiting

Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adherence

Gastroesophageal Reflux Disease | GERD | Non-erosive Reflux Disease | Erosive Esophagitis | Non-Erosive Gastro-Esophageal Reflux Disease | Gastroesophageal Erosion

Russian Federation
Kuros Biosurgery AG

Completed

A Dose Finding Study of Topically Applied I-020201 as an Adjunct to Good Standard-of-care in Patients With Chronic Diabetic Foot Ulcers (DFU)

Diabetic Foot Ulcer

Czech Republic, Germany, Hungary, Romania, Russian Federation, Serbia
AstraZeneca

Completed

A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer

Gastrointestinal Hemorrhage

Sweden, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Germany, Romania, Finland, Norway, Hong Kong, Austria, Denmark, Netherlands, Greece, France
Pfizer

Completed

Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (FEENICS)

Diabetic Foot Ulcer

Canada, Greece, Austria, Finland, Poland, Sweden, Russian Federation, Norway, Spain, Italy, United Kingdom, Denmark, Lithuania, Belgium, Germany, Ukraine, Czechia
sigma-tau i.f.r. S.p.A.

Completed

Propionyl-L-Carnitine in Ulcerative Colitis

Ulcerative Colitis

Italy, Lithuania, Poland, Russian Federation
Actelion

Terminated

Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients (DUAL-2)

Digital Ulcers

Spain, United States, Argentina, China, Ireland, Colombia, Israel, New Zealand, Germany, Belgium, Portugal, Netherlands, South Africa, Greece, Mexico, Poland, Puerto Rico, Russian Federation, Turkey, Ukraine, United Kingdom
Novo Nordisk A/S

Terminated

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Inflammation | Ulcerative Colitis

Poland, Croatia, Denmark, Bulgaria, Hungary, Ukraine, Russian Federation
Renovo

Completed

Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites

Trauma | Burn | Varicose Ulcer

United Kingdom, Russian Federation, Germany, Latvia
Novartis Pharmaceuticals

Terminated

Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis

Colitis, Ulcerative

Russian Federation, Czechia, Bulgaria, Germany, Poland, Slovakia
Actelion

Completed

Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients (DUAL-1)

Systemic Sclerosis | Ulcers

Canada, United States, Belarus, Hungary, Croatia, Australia, Denmark, Ukraine, Bulgaria, Chile, Colombia, Czech Republic, Finland, Germany, India, Italy, Poland, Russian Federation
Sanofi

Completed

Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study (NICE)

Ulcerative Colitis | Inflammatory Bowel Disease

Canada, Brazil, Russian Federation, Italy, Spain, Sweden, Estonia, Singapore, Belgium, Czech Republic, Argentina, Hungary, Chile, South Africa
Abbott

Terminated

Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)

Ulcerative Colitis

United States, Canada, Croatia, Italy, Russian Federation, Spain
Kyowa Kirin, Inc.

Completed

Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis

Digestive System Diseases | Gastrointestinal Diseases | Colonic Diseases | Intestinal Diseases | Abdominal Pain | Inflammatory Bowel Diseases | Ulcerative Colitis | Colitis | Colitis, Ulcerative | Autoimmune Disease

Hungary, Russian Federation, Serbia, United States, Poland, Czechia, Romania
Galapagos NV

Completed

Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis (ORIGIN)

Ulcerative Colitis

Belgium, Czech Republic, Germany, Hungary, Poland, Russian Federation
GlaxoSmithKline

Completed

GSK2982772 Study in Subjects With Ulcerative Colitis

Colitis, Ulcerative

Netherlands, United States, Germany, Russian Federation, Sweden, Poland, United Kingdom
AstraZeneca

Completed

Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA) (Oberon)

Gastric Ulcer | Duodenal Ulcer

United States, Bulgaria, Czech Republic, Korea, Republic of, Russian Federation, South Africa, Philippines, Poland, Romania, Finland, Norway, Canada, Mexico, Argentina, Australia, Germany, Portugal, Slovakia, Thailand, Indonesia
OSE Immunotherapeutics

Recruiting

Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis (CoTikiS)

Ulcerative Colitis

Belgium, Latvia, Bulgaria, Belarus, Croatia, Georgia, Hungary, Poland, Russian Federation, South Africa, Ukraine
Biogen

Completed

A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis

Active Ulcerative Colitis

United States, Canada, Czech Republic, Hungary, Poland, Russian Federation, Slovakia
Boehringer Ingelheim

Completed

BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis

Colitis, Ulcerative

Spain, United Kingdom, United States, Belgium, Germany, Italy, Austria, Canada, Japan, Korea, Republic of, Russian Federation, Poland
Bayer

Completed

Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection

Diabetic Foot | Ulcer | Abscess | Wound Infection

Italy, Spain, Greece, Ireland, Russian Federation, United Kingdom, Germany, Austria, Belgium, France, Hungary, South Africa, Romania, Bulgaria, Poland, Israel, Latvia, Ukraine, Lithuania, Netherlands
Bristol-Myers Squibb

Completed

A Study of MDX-1100 in Subjects With Active Ulcerative Colitis (MDX1100-06)

Ulcerative Colitis

Ukraine, United States, Romania, Russian Federation, Czech Republic, Hungary, Canada, Latvia
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Colitis, Ulcerative

France, Ukraine, United States, Poland, Bulgaria, Canada, Netherlands, Belgium, Russian Federation, Germany, Hungary, Czech Republic
Janssen Research & Development, LLC

Active, not recruiting

A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC) (UNIFI Jr)

Colitis, Ulcerative

United States, Israel, Belgium, Hungary, Japan, Germany, Poland, United Kingdom, Russian Federation
GB004, Inc.

Terminated

A Study With GB004 in Adult Subjects With Active Ulcerative Colitis (UC)

Ulcerative Colitis

United States, Korea, Republic of, Serbia, Ukraine, Romania, Georgia, Russian Federation, Moldova, Republic of, Poland
InDex Pharmaceuticals

Completed

The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis (CONDUCT)

Ulcerative Colitis

Hungary, Czechia, France, Germany, Poland, Russian Federation, Serbia, Spain, Sweden, Ukraine
Boehringer Ingelheim

Completed

BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis

Colitis, Ulcerative

Canada, United States, Spain, United Kingdom, Belgium, Germany, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Austria
Warner Chilcott

Terminated

Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis (CAMPIII)

Ulcerative Colitis

United States, Canada, Croatia, Russian Federation, Poland, Romania
GlaxoSmithKline

Terminated

Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis

Colitis, Ulcerative

United States, Netherlands, Ukraine, Estonia, Poland, France, Japan, Russian Federation, Slovakia, South Africa, United Kingdom, India, Bulgaria, Czechia, Serbia
Bausch Health Americas, Inc.
Cosmo Technologies Ltd

Completed

(CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis

Ulcerative Colitis

Russian Federation, United Kingdom, Latvia, Poland, Estonia, Belgium, Australia, Lithuania, France, Sweden, Israel, Italy, Romania, Slovakia, Ukraine
sigma-tau i.f.r. S.p.A.

Terminated

Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis

Ulcerative Colitis

Netherlands, Romania, Israel, Czech Republic, Italy, Belgium, Russian Federation, Slovakia
NImmune Biopharma

Completed

Efficacy and Safety of Oral BT-11 in Ulcerative Colitis

Ulcerative Colitis

United States, Bosnia and Herzegovina, Croatia, Poland, Ukraine
Takeda

Completed

Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets

Inflammatory Bowel Diseases | Crohn Disease | Colitis, Ulcerative

China, Korea, Republic of, Taiwan, Russian Federation, Turkey, Argentina, Colombia, Mexico, Saudi Arabia, Singapore
Bristol-Myers Squibb

Completed

A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis

Crohn Disease | Ulcerative Colitis

Romania, Italy, United States, Australia, Canada, China, Germany, Hungary, Japan, Netherlands, Poland, Portugal, Russian Federation, Spain, Taiwan, United Kingdom
Ferring Pharmaceuticals

Completed

Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)

Ulcerative Colitis

Switzerland, Russian Federation, Latvia, United States, Hungary, Ukraine, Bulgaria, Canada, Mexico, Poland, Serbia

Clinical Trials on Penetrating Ulcers in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations